OXON Medical is coming soon.
OXON Medical represents pioneering cannabinoid research, innovation and quality assurance.
Research and product development conducted by Equinox and our partner institutions, including Oxford Antibiotic Group, serves as the bedrock for the OXON range of medicines.
OXON Medical products are designed to meet European and International pharmaceutical standards, and target the most common diseases, including chronic pain, neurological disorder and many gastrointestinal diseases.
OXON Medical cannabis products offer dosing precision, discretion and ease of use. We develop unique and proprietary formulations of cannabis-based medical products for the European and international markets.
Our product range includes:
- Pharmaceutical-grade flowers and extracts in various concentrations
- A range of medical devices and applications to suit patient preference and administration
- Cannabinoid (THC, CBD, CBG, et al) products, formulations, oils, capsules, tinctures and lotions
All of our medical products are organic and produced in accordance with EU Good Manufacturing Practice (GMP).
We cultivate cannabis in accordance with Good Agricultural Practices. Each harvest is grown under controlled conditions where temperature, humidity, photoperiod and the levels of oxygen and carbon dioxide are optimised and continuously monitored.
OXON Medical products undergo rigorous safety and quality assessment to ensure the standardisation and consistency of THC, CBD andCBG as well as absence of bacteria, moulds, pesticides and heavy metals.
At Equinox we are continuously making efforts to advance our understanding of the role of medical cannabis and THC, CBD and CBG in maintaining health and wellbeing.
If you have any questions about OXON Medical or any of our products, we would love to hear from you. Please get in touch via our Contact page.